Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood–Brain Barrier in Patients with Glioblastoma

Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood–Brain Barrier in Patients with Glioblastoma

Currently, the mechanisms involved in drug access to the central nervous system (CNS) are not completely elucidated, and research efforts to understand the behaviour of the therapeutic agents to access the blood–brain barrier continue with the utmost importance. The aim of this work was the creation...

Full description

Bibliographic Details
Main Authors:	Bárbara Sánchez-Dengra, Elena García-Montoya, Isabel González-Álvarez, Marival Bermejo, Marta González-Álvarez
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Pharmaceutics
Subjects:	blood–brain barrier (BBB) cell culture glioblastoma permeability in vitro–in vivo correlations (IVIVC) transepithelial electrical resistance (TEER)
Online Access:	https://www.mdpi.com/1999-4923/15/5/1431

Similar Items

Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
by: Andrés Figueroa-Campos, et al.
Published: (2020-07-01)

In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine
by: Tuba Incecayir, et al.
Published: (2023-10-01)

Brain targeted delivery of paclitaxel using endogenous ligand
by: Sanjeev R. Acharya, et al.
Published: (2016-06-01)

PerfuPul—A Versatile Perfusable Platform to Assess Permeability and Barrier Function of Air Exposed Pulmonary Epithelia
by: Patrick Carius, et al.
Published: (2021-10-01)

In Vitro–In Vivo Correlations Based on In Vitro Dissolution of Parent Drug Diltiazem and Pharmacokinetics of Its Metabolite
by: Constantin Mircioiu, et al.
Published: (2019-07-01)

Establishing Co-Culture Blood–Brain Barrier Models for Different Neurodegeneration Conditions to Understand Its Effect on BBB Integrity
by: Jun Sung Park, et al.
Published: (2023-03-01)

Experimental Models to Study the Functions of the Blood–Brain Barrier
by: Andrzej Łach, et al.
Published: (2023-04-01)

Canine Epidermal Keratinocytes (CPEK) Grown in Monolayer Are Not Representative of Normal Canine Keratinocytes for Permeability Studies: Pilot Studies
by: Rosanna Marsella, et al.
Published: (2022-01-01)

Long-Acting Injectable Antipsychotics—A Review on Formulation and In Vitro Dissolution
by: Magdalena Markowicz-Piasecka, et al.
Published: (2023-12-01)

A Novel Transwell Blood Brain Barrier Model Using Primary Human Cells
by: Nicole L. Stone, et al.
Published: (2019-06-01)

Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases
by: Simon Bernatz, et al.
Published: (2019-10-01)

An Improved In Vitro Blood-Brain Barrier Model for the Evaluation of Drug Permeability Using Transwell with Shear Stress
by: Junhyeong Kim, et al.
Published: (2023-12-01)

Filter exchange imaging with crusher gradient modelling detects increased blood–brain barrier water permeability in response to mild lung infection
by: Yolanda Ohene, et al.
Published: (2023-04-01)

Introducing an In Vitro Liver Stability Assay Capable of Predicting the In Vivo Pharmacodynamic Efficacy of siRNAs for IVIVC
by: Babak Basiri, et al.
Published: (2020-09-01)

Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
by: Nadin Rabah, et al.
Published: (2023-09-01)

Intestinal Alkaline Phosphatase Prevents Sulfate Reducing Bacteria-Induced Increased Tight Junction Permeability by Inhibiting Snail Pathway
by: Sudha B. Singh, et al.
Published: (2022-05-01)

Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells
by: W. Cui, et al.
Published: (2010-04-01)

A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule
by: Pawan Kumar Gupta, et al.
Published: (2024-01-01)

Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients
by: Halil Ibrahim Toy, et al.
Published: (2022-10-01)

Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery
by: Elisa L. J. Moya, et al.
Published: (2021-06-01)

SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood–Brain Barrier
by: Kinga Molnár, et al.
Published: (2021-01-01)

IVIVC assessment, pharmacokinetic evaluation, and X-ray radiography mapping of Novel Parteck® SRP 80 and hypromellose-loaded LTD4 receptor antagonist chronosystem
by: Saniya Jawed, et al.
Published: (2023-11-01)

New In Vitro Methodology for Kinetics Distribution Prediction in the Brain. An Additional Step towards an Animal-Free Approach
by: Bárbara Sánchez-Dengra, et al.
Published: (2021-12-01)

Modulating the Blood–Brain Barrier: A Comprehensive Review
by: Rory Whelan, et al.
Published: (2021-11-01)

Development of targeted therapies in treatment of glioblastoma
by: Yuan-Yuan Xu, et al.
Published: (2015-09-01)

In situ sensors for blood-brain barrier (BBB) on a chip
by: Yan Liang, et al.
Published: (2021-11-01)

In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
by: Marival Bermejo, et al.
Published: (2020-06-01)

One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products
by: Mercedes Prieto-Escolar, et al.
Published: (2021-05-01)

In Vitro–In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action
by: Seeprarani Rath, et al.
Published: (2023-01-01)

Mucin-degrading gut commensals isolated from healthy faecal donor suppress intestinal epithelial inflammation and regulate tight junction barrier function
by: Mingfang Pan, et al.
Published: (2022-10-01)

The Bioactive Phenolic Agents Diaryl Ether CVB2-61 and Diarylheptanoid CVB4-57 as Connexin Hemichannel Blockers
by: Anne Dierks, et al.
Published: (2022-09-01)

Glioblastoma Multiforme—A Look at the Past and a Glance at the Future
by: Jasmine L. King, et al.
Published: (2021-07-01)

Advancements in nanoengineered paclitaxel formulations: A comprehensive review of blood-brain barrier infiltration strategies for glioblastoma therapy
by: Stabak Das, et al.
Published: (2024-06-01)

BBB-on-a-chip with integrated micro-TEER for permeability evaluation of multi-functionalized gold nanorods against Alzheimer’s disease
by: Sujey Palma-Florez, et al.
Published: (2023-03-01)

Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
by: Bárbara Sánchez-Dengra, et al.
Published: (2021-09-01)

In vivo dissolution of poorly water-soluble drugs: Proof of concept based on fluorescence bioimaging
by: Yinqian Yang, et al.
Published: (2021-04-01)

A deep learning approach to predict blood-brain barrier permeability
by: Shrooq Alsenan, et al.
Published: (2021-06-01)

Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood–brain barrier and target glioma
by: Xuemei Ji, et al.
Published: (2019-10-01)

Localized Increased Permeability of Blood–Brain Barrier for Antibody Conjugates in the Cuprizone Model of Demyelination
by: Tatiana Abakumova, et al.
Published: (2023-08-01)

Medical Device Advances in the Treatment of Glioblastoma
by: Cher Ying Foo, et al.
Published: (2022-10-01)